EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)

NCT00982605 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2009-10-06

No results posted yet for this study

Summary

The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).

Conditions

  • Non Small Cell Lung Cancer

Interventions

PROCEDURE

EBUS_TBNA

EBUS during bronchoscopy

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Michael Kreuter, MD · Thoraxklinik Heidelberg, Germany

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-10-31
Completion
2011-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00982605 on ClinicalTrials.gov